Skip to Main Content

Author Details

Mark Puder
Boston Children's Hospital, Harvard Medical School
1993
200
44
PMIDPaper TitleJournal TitlePublished Year
36195630Effects of systemic anticoagulation in a murine model of compensatory lung growth.Pediatr Res2023
37827157A pneumonectomy model to study flow-induced pulmonary hypertension and compensatory lung growth.Cell Rep Methods2023
38039287A medium-chain fatty acid analogue prevents hepatosteatosis and decreases inflammatory lipid metabolites in a murine model of parenteral nutrition-induced hepatosteatosis.PLoS One2023
37726175Absorption of an engineered medium-chain fatty acid analogue in two short bowel syndrome minipig models.JPEN J Parenter Enteral Nutr2023
37187742PR1P, a VEGF-stabilizing peptide, reduces injury and inflammation in acute lung injury and ulcerative colitis animal models.Front Immunol2023
37170358IMPOWER: a national patient-generated registry for intestinal malrotation exploring diagnosis, treatment, and surgical outcomes.Orphanet J Rare Dis2023
37070823Ethanol lock therapy increases mechanical catheter complications in a pediatric intestinal failure population: A retrospective cohort study.JPEN J Parenter Enteral Nutr2023
37263310A Medium-Chain Fatty Acid Analogue Prevents Intestinal Failure-Associated Liver Disease in Preterm Yorkshire Piglets.Gastroenterology2023
37260177Pericytes Contribute to Flow-induced Pulmonary Hypertension.Am J Respir Cell Mol Biol2023
36924229A Digestive Cartridge Reduces Parenteral Nutrition Dependence and Increases Bowel Growth in a Piglet Short Bowel Model.Ann Surg2023
36857339Fat digestion using RELiZORB in children with short bowel syndrome who are dependent on parenteral nutrition: Protocol for a 90-day, phase 3, open labeled study.PLoS One2023
36798332Efficient megakaryopoiesis and platelet production require phospholipid remodeling and PUFA uptake through CD36.bioRxiv2023
36308408Incidence and development of cholestasis in surgical neonates receiving an intravenous mixed-oil lipid emulsion.JPEN J Parenter Enteral Nutr2023
34695449Use of Intravenous Soybean and Fish Oil Emulsions in Pediatric Intestinal Failure-Associated Liver Disease: A Multicenter Integrated Analysis Report on Extrahepatic Adverse Events.J Pediatr2022
35715592Lipopolysaccharide-induced murine lung injury results in long-term pulmonary changes and downregulation of angiogenic pathways.Sci Rep2022
35778847Structurally-engineered fatty acid 1024 (SEFA-1024) improves diet-induced obesity, insulin resistance, and fatty liver disease.Lipids2022
35413571An in-line digestive cartridge increases enteral fat and vitamin absorption in a porcine model of short bowel syndrome.Clin Nutr2022
36477689Direct thrombin inhibitors as alternatives to heparin to preserve lung growth and function in a murine model of compensatory lung growth.Sci Rep2022
36601582Targeting the lung endothelial niche to promote angiogenesis and regeneration: A review of applications.Front Mol Biosci2022
36313875Current and emerging adjuvant therapies in biliary atresia.Front Pediatr2022
35123284Outcomes and Perioperative Nutritional Management in a Porcine Model of Short Bowel Syndrome.J Surg Res2022
32149998Prediction of the Development of Severe Sepsis Among Children With Intestinal Failure and Fever Presenting to the Emergency Department.Pediatr Emerg Care2021
33897464Free Fatty Acid Receptors as Mediators and Therapeutic Targets in Liver Disease.Front Physiol2021
34375128Visual Dysfunction after Repetitive Mild Traumatic Brain Injury in a Mouse Model and Ramifications on Behavioral Metrics.J Neurotrauma2021
34569654Deficiency in pigment epithelium-derived factor accelerates pulmonary growth and development in a compensatory lung growth model.FASEB J2021
34352771Prevention and Management of Parenteral Nutrition-Associated Cholestasis and Intestinal Failure-Associated Liver Disease in the Critically Ill Infant.World Rev Nutr Diet2021
34070133Dietary Ï¿-3 Fatty Acid Supplementation Improves Murine Sickle Cell Bone Disease and Reprograms Adipogenesis.Antioxidants (Basel)2021
34088930Investigation of the mechanisms of VEGF-mediated compensatory lung growth: the role of the VEGF heparin-binding domain.Sci Rep2021
33356650Current strategies for managing intestinal failure-associated liver disease.Expert Opin Drug Saf2021
33264184One-year Experience With Composite Intravenous Lipid Emulsion in Children on Home Parenteral Nutrition.J Pediatr Gastroenterol Nutr2021
33038344Fish Oil Emulsion Reduces Liver Injury and Liver Transplantation in Children with Intestinal Failure-Associated Liver Disease: A Multicenter Integrated Study.J Pediatr2021
31567890Antibiotic Susceptibility and Therapy in Central Line Infections in Pediatric Home Parenteral Nutrition Patients.J Pediatr Gastroenterol Nutr2020
32059815Intravenous Fish Oil Monotherapy as a Source of Calories and Fatty Acids Promotes Age-Appropriate Growth in Pediatric Patients with Intestinal Failure-Associated Liver Disease.J Pediatr2020
31978030Growth in Infants and Children With Intestinal Failure-associated Liver Disease Treated With Intravenous Fish Oil.J Pediatr Gastroenterol Nutr2020
32663413PR1P Stabilizes VEGF and Upregulates Its Signaling to Reduce Elastase-induced Murine Emphysema.Am J Respir Cell Mol Biol2020
32687916Optimizing Duration of Empiric Management of Suspected Central Line-Associated Bloodstream Infections in Pediatric Patients with Intestinal Failure.J Pediatr2020
32666268Roxadustat (FG-4592) accelerates pulmonary growth, development, and function in a compensatory lung growth model.Angiogenesis2020
32140799Free fatty acid receptor 4 activation protects against choroidal neovascularization in mice.Angiogenesis2020
31549454Use of Fish Oil Intravenous Lipid Emulsions as Monotherapy in the Pediatric Intestinal Failure Patient: Beyond the Package Insert.Nutr Clin Pract2020
31282035Trends of INR and Fecal Excretion of Vitamin K During Cholestasis Reversal: Implications in the Treatment of Neonates With Intestinal Failure-Associated Liver Disease.JPEN J Parenter Enteral Nutr2020
29603280Commentary on "Fish Oil-Containing Lipid Emulsions in Adult Parenteral Nutrition: A Review of the Evidence".JPEN J Parenter Enteral Nutr2019
30224305Effects of dietary omega-3 fatty acids on bones of healthy mice.Clin Nutr2019
29846008Essential Fatty Acid Status in Surgical Infants Receiving Parenteral Nutrition With a Composite Lipid Emulsion: A Case Series.JPEN J Parenter Enteral Nutr2019
31331633The evolving use of intravenous lipid emulsions in the neonatal intensive care unit.Semin Perinatol2019
31295333Alpha-tocopherol in intravenous lipid emulsions imparts hepatic protection in a murine model of hepatosteatosis induced by the enteral administration of a parenteral nutrition solution.PLoS One2019
31435972Metabolic and Inflammatory Effects of an Ï¿-3 Fatty Acid-Based Eucaloric Ketogenic Diet in Mice With Endotoxemia.JPEN J Parenter Enteral Nutr2019
31036368Omega-3 fatty acids are protective in hepatic ischemia reperfusion injury in the absence of GPR120 signaling.J Pediatr Surg2019
30858795A Diet With Docosahexaenoic and Arachidonic Acids as the Sole Source of Polyunsaturated Fatty Acids Is Sufficient to Support Visual, Cognitive, Motor, and Social Development in Mice.Front Neurosci2019
30975380Fish oil protects the liver from parenteral nutrition-induced injury via GPR120-mediated PPARγ signaling.Prostaglandins Leukot Essent Fatty Acids2019
30882140Fish oil-based injectable lipid emulsions containing medium-chain triglycerides or added α-tocopherol offer anti-inflammatory benefits in a murine model of parenteral nutrition-induced liver injury.Am J Clin Nutr2019
  • 1 - 50 of 200

Recommended Authors

Vanderbilt University Medical Center
Career Start Year 2007
Number of shared co-authors 0
University of Florida, College of Medicine-Jacksonville
Career Start Year 2006
Number of shared co-authors 0
Nationwide Children's Hospital
Career Start Year 2005
Number of shared co-authors 0
Universidad San Pablo-CEU
Career Start Year 2004
Number of shared co-authors 0
and Vascular Medicine Institute, University of Pittsburgh
Career Start Year 2004
Number of shared co-authors 0
Cincinnati Children's Hospital Medical Center
Career Start Year 2003
Number of shared co-authors 1
Children's Hospital Los Angeles
Career Start Year 2001
Number of shared co-authors 1
Boston Children's Hospital
Career Start Year 2001
Number of shared co-authors 1
Intermountain Medical Center
Career Start Year 2000
Number of shared co-authors 1
University of Virginia
Career Start Year 2000
Number of shared co-authors 0
College of Medicine, University of Florida
Career Start Year 1999
Number of shared co-authors 0
Boehringer Ingelheim Pharma GmbH & Co. KG
Career Start Year 1998
Number of shared co-authors 0
University of California San Diego
Career Start Year 1997
Number of shared co-authors 0
University of Nebraska Medical Center
Career Start Year 1997
Number of shared co-authors 1
UPMC Children's Hospital of Pittsburgh.
Career Start Year 1995
Number of shared co-authors 1
Hunterdon Medical Center
Career Start Year 1990
Number of shared co-authors 0
Virginia Commonwealth University
Career Start Year 1989
Number of shared co-authors 0
University of Washington
Career Start Year 1989
Number of shared co-authors 0
Emory University School of Medicine
Career Start Year 1988
Number of shared co-authors 2
Mie University
Career Start Year 1988
Number of shared co-authors 0
Children's Hospital of Pittsburgh
Career Start Year 1987
Number of shared co-authors 1
University of Southern California Keck School of Medicine
Career Start Year 1985
Number of shared co-authors 0
The Hospital for Sick Children
Career Start Year 1983
Number of shared co-authors 0
University of Zambia
Career Start Year 1981
Number of shared co-authors 0
University of Colorado School of Medicine
Career Start Year 1978
Number of shared co-authors 0
Ann and Robert H Lurie Children's Hospital of Chicago
Career Start Year 1977
Number of shared co-authors 1
Cincinnati Children's Hospital Medical Center
Career Start Year 1975
Number of shared co-authors 2
IRCCS Centro Neurolesi Messina
Career Start Year 1967
Number of shared co-authors 0
Digestive Health Institute, Children's Hospital Colorado
Career Start Year 1964
Number of shared co-authors 1
Bicetre Medical Centre, Paris Saclay University
Career Start Year 1963
Number of shared co-authors 1

Collaborators

University of Pennsylvania
Co-authored papers 5
Harvard Medical School, Boston Children's Hospital
Co-authored papers 5
Boston Children's Hospital and Harvard Medical School
Co-authored papers 3
Center for Translational Research in Aging & Longevity, Texas A&M University
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University (OHSU)
Co-authored papers 2
Boston Children's Hospital, Harvard Medical School
Co-authored papers 2
Boston Children's Hospital
Co-authored papers 2
Boston Children's Hospital
Co-authored papers 2
Boston Children's Hospital
Co-authored papers 2
Princess Maxima Center for Pediatric Oncology
Co-authored papers 1
Harvard Medical School
Co-authored papers 1
4Division of Pediatric Gastroenterology and Nutrition,Maine Medical Center
Co-authored papers 1
Boston Children's Hospital, Harvard Medical School
Co-authored papers 1
University of Pittsburgh School of Medicine, UPMC Children's Hospital of Pittsburgh
Co-authored papers 1
Boston Children's Hospital, Harvard Medical School
Co-authored papers 1
Boston Children's Hospital
Co-authored papers 1
Boston Children's Hospital
Co-authored papers 1
Harvard Medical School
Co-authored papers 1
Boston Children's Hospital
Co-authored papers 1
Boston Children's Hospital, Harvard Medical School
Co-authored papers 1
Children's Hospital Colorado
Co-authored papers 1
Boston Children's Hospital
Co-authored papers 1
Co-authored papers 1
Boston Children's Hospital
Co-authored papers 1
Boston Children's Hospital, Harvard Medical School
Co-authored papers 1
University Hospitals Cleveland Medical Center
Co-authored papers 1